Clinical Trials Using Deuterated Phenanthrene

Clinical trials are research studies that involve people. The clinical trials on this list are studying Deuterated Phenanthrene. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Brussel Sprout Consumption in Affecting Deuterated Phenanthrene Metabolism in Current and Former Smokers

    This pilot clinical trial studies how Brussel sprout consumption affects deuterated phenanthrene metabolism in current and former smokers. Cigarette smoke contains many chemicals called carcinogens which are known to cause cancer. Deuterated phenanthrene is a chemical that does not cause cancer but is processed by the body in the same way as some carcinogens in cigarette smoke or pollution. Brussel sprouts contain a chemical called glucobrassicin that may prevent cancer. Giving participants deuterated phenanthrene and raw Brussel sprouts and studying urine samples in a laboratory may help doctors understand how Brussel sprouts affect the breakdown of deuterated phenanthrene and help doctors figure out which smokers may be at risk for lung cancer.
    Location: University of Minnesota / Masonic Cancer Center, Minneapolis, Minnesota